Alfimeprase

alfimeprase · ARCA Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Alfimeprase, covering 2008-01-15 to 2010-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices [Phase 2]